Kalaris Therapeutics (KLRS) Return on Capital Employed [ROCE] (2020 - 2026)
Kalaris Therapeutics (KLRS) recorded Return on Capital Employed [ROCE] of -49.79% in Q2 2026, up 25.05 percentage points from -74.84% a year earlier but down 5.56 percentage points from the prior quarter.
Powered by 
Analysis
Kalaris Therapeutics (KLRS) Return on Capital Employed [ROCE] (2020 - 2026) Analysis & Trends
For FY2025, Kalaris Therapeutics reported Return on Capital Employed [ROCE] of -85.10%, down 14.98 percentage points from FY2024.
- Annual Return on Capital Employed [ROCE] has a five-year change of -55.73 percentage points (FY2020 to FY2025).
- Across earlier years, Return on Capital Employed [ROCE] came in at -70.12% in FY2024 (+27.12 pp), -97.24% in FY2023 (-30.76 pp), -66.49% in FY2022 (-8.10 pp) and -58.39% in FY2021 (-29.02 pp).
- Quarterly Return on Capital Employed [ROCE] has ranged from -130.49% in Q4 2024 to -44.23% in Q1 2026 over the past five years.
- On a year-over-year basis, Return on Capital Employed [ROCE] has increased for five consecutive quarters, with an average year-over-year change of +21.23 percentage points over the last eight quarters.
- Peak year-over-year performance for Return on Capital Employed [ROCE] in the last five years was a gain of 81.12 percentage points in Q1 2026, against a drop of 60.53 percentage points in Q2 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at -44.23% (Q1 2026), -50.31% (Q4 2025) and -52.49% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.86% |
| 10 | Kalaris Therapeutics | 64.27 Mn | 64.27 Mn | - | -49.79% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -49.79% |
| Mar 31, 2026 | -44.23% |
| Dec 31, 2025 | -50.31% |
| Sep 30, 2025 | -52.49% |
| Jun 30, 2025 | -74.84% |
| Mar 31, 2025 | -125.35% |
| Dec 31, 2024 | -130.49% |
| Sep 30, 2024 | -85.37% |
| Jun 30, 2024 | -85.88% |
| Mar 31, 2024 | -99.64% |
| Dec 31, 2023 | -104.56% |
| Sep 30, 2023 | -76.55% |
| Jun 30, 2023 | -74.71% |
| Mar 31, 2023 | -72.68% |
| Dec 31, 2022 | -65.58% |
| Sep 30, 2022 | -82.50% |
| Jun 30, 2022 | -97.51% |
| Mar 31, 2022 | -75.83% |
| Dec 31, 2021 | -64.40% |
| Sep 30, 2021 | -46.82% |
API Access
Kalaris Therapeutics Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=KLRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "KLRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=KLRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();